Compounds > midodrine

midodrine and terlipressin

midodrine has been researched along with terlipressin in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (22.22)29.6817
2010's11 (61.11)24.3611
2020's3 (16.67)2.80

Authors

AuthorsStudies
Calahorra, B; Ginès, P; Ortega, R1
Kalambokis, GN; Tsianos, EV1
Bendtsen, F; Borup, T; Krag, A; Møller, S1
Alessandria, C; Carello, M; Ceretto, S; Debernardi-Venon, W; Marzano, A; Rizzetto, M1
Hasper, D; Jörres, A1
Hsu, SJ; Huang, HC1
Angeli, P; Bernardi, M; Caraceni, P; Cavallin, M; Colletta, C; Di Giacomo, A; Fasolato, S; Fornasiere, E; Gatta, A; Kamath, PS; Merli, M; Morando, F; Piano, S; Ridola, L; Romanelli, RG; Salerno, F; Salinas, F; Toniutto, P1
Wong, F1
Edrees, AM; El-Abd, OL; El-Azab, GI; El-Said, HH; Salman, TA1
Bertino, G; Crisafulli, E; Demma, S; Koukias, N; Privitera, G; Purrello, F; Spadaro, L; Tsochatzis, EA1
Chandar, AK; Facciorusso, A; Kamath, PS; Murad, MH; Muscatiello, N; Prokop, LJ; Singh, S1
Allegretti, AS; Gluud, LL; Goldin, AH; Israelsen, M; Jovani, M; Krag, A; Winter, RW1
Nanda, A; Reddy, R; Safraz, H; Salameh, H; Singal, AK1
Baltayiannis, G; Christodoulou, D; Christou, L; Kalambokis, GN1
Colle, I; Laterre, PF1
Lok, AS; Sharma, P; Tapper, EB; Taylor, A; Thomson, MJ1
Alhazzani, W; Bagshaw, SM; Dionne, JC; Helmeczi, W; Kiflen, M; Needham-Nethercott, N; Pitre, T; Rewa, O; Rochwerg, B; Zeraatkar, D1
Ahn, J; Flamm, SL; Kamath, PS; Wong, F1

Reviews

13 review(s) available for midodrine and terlipressin

ArticleYear
[Vasoconstrictors in the treatment of hepatorenal syndrome].
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2002, Volume: 22 Suppl 5

    Topics: Adrenergic alpha-Agonists; Albumins; Drug Evaluation; Drug Therapy, Combination; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Midodrine; Octreotide; Ornipressin; Pilot Projects; Renal Circulation; Terlipressin; Vasoconstrictor Agents

2002
Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome.
    Advances in therapy, 2008, Volume: 25, Issue:11

    Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hemodynamics; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Liver Failure, Acute; Lypressin; Midodrine; Norepinephrine; Octreotide; Paracentesis; Randomized Controlled Trials as Topic; Somatostatin; Terlipressin; Vasoconstrictor Agents

2008
New insights into the management of hepato-renal syndrome.
    Liver international : official journal of the International Association for the Study of the Liver, 2011, Volume: 31 Suppl 3

    Topics: Disease Management; Hepatorenal Syndrome; Humans; Lypressin; Midodrine; Norepinephrine; Renal Dialysis; Terlipressin

2011
Management of ascites in patients with liver cirrhosis: recent evidence and controversies.
    Journal of the Chinese Medical Association : JCMA, 2013, Volume: 76, Issue:3

    Topics: Ascites; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Midodrine; Portasystemic Shunt, Transjugular Intrahepatic; Propranolol; Terlipressin

2013
Diagnosing and treating renal disease in cirrhotic patients.
    Minerva gastroenterologica e dietologica, 2016, Volume: 62, Issue:3

    Topics: Creatinine; Glomerular Filtration Rate; Humans; Kidney Diseases; Liver Cirrhosis; Liver Transplantation; Lypressin; Midodrine; Norepinephrine; Portasystemic Shunt, Surgical; Renal Replacement Therapy; Terlipressin; Vasoconstrictor Agents

2016
Emerging hepatic syndromes: pathophysiology, diagnosis and treatment.
    Internal and emergency medicine, 2016, Volume: 11, Issue:7

    Topics: Acute Kidney Injury; Adrenal Insufficiency; Ascites; Creatinine; Evidence-Based Medicine; Hepatorenal Syndrome; Humans; Hypertension, Portal; Liver Cirrhosis; Liver Transplantation; Lypressin; Midodrine; Norepinephrine; Octreotide; Plasma Substitutes; Portasystemic Shunt, Transjugular Intrahepatic; Serum Albumin; Terlipressin; Vasodilator Agents; Vasopressins

2016
Comparative efficacy of pharmacological strategies for management of type 1 hepatorenal syndrome: a systematic review and network meta-analysis.
    The lancet. Gastroenterology & hepatology, 2017, Volume: 2, Issue:2

    Topics: Dopamine; Drug Therapy, Combination; Gastrointestinal Agents; Hepatorenal Syndrome; Humans; Lypressin; Midodrine; Network Meta-Analysis; Norepinephrine; Octreotide; Terlipressin; Treatment Outcome; Vasoconstrictor Agents

2017
Terlipressin versus other vasoactive drugs for hepatorenal syndrome.
    The Cochrane database of systematic reviews, 2017, 09-27, Volume: 9

    Topics: Antihypertensive Agents; Dopamine; Hepatorenal Syndrome; Humans; Lypressin; Midodrine; Norepinephrine; Octreotide; Randomized Controlled Trials as Topic; Terlipressin; Vasoconstrictor Agents

2017
Pharmacological Therapies for Hepatorenal Syndrome: A Systematic Review and Meta-Analysis.
    Journal of clinical gastroenterology, 2018, Volume: 52, Issue:4

    Topics: Albumins; Drug Therapy, Combination; Hepatorenal Syndrome; Humans; Infusions, Intravenous; Midodrine; Octreotide; Randomized Controlled Trials as Topic; Terlipressin; Vasoconstrictor Agents

2018
Hepatorenal syndrome: the clinical impact of vasoactive therapy.
    Expert review of gastroenterology & hepatology, 2018, Volume: 12, Issue:2

    Topics: Biomarkers; Creatinine; Hepatorenal Syndrome; Humans; Lypressin; Midodrine; Norepinephrine; Octreotide; Practice Guidelines as Topic; Predictive Value of Tests; Risk Factors; Terlipressin; Treatment Outcome; Vasoconstriction; Vasoconstrictor Agents

2018
Limited Progress in Hepatorenal Syndrome (HRS) Reversal and Survival 2002-2018: A Systematic Review and Meta-Analysis.
    Digestive diseases and sciences, 2020, Volume: 65, Issue:5

    Topics: Adult; Albumins; Anti-Bacterial Agents; Dopamine; Drug Therapy, Combination; Female; Hepatorenal Syndrome; Humans; Male; Middle Aged; Midodrine; Norepinephrine; Octreotide; Plasma Substitutes; Randomized Controlled Trials as Topic; Regression Analysis; Survival Rate; Terlipressin; Treatment Outcome; Vasoconstrictor Agents; Young Adult

2020
The Comparative Effectiveness of Vasoactive Treatments for Hepatorenal Syndrome: A Systematic Review and Network Meta-Analysis.
    Critical care medicine, 2022, 10-01, Volume: 50, Issue:10

    Topics: Hepatorenal Syndrome; Humans; Midodrine; Network Meta-Analysis; Norepinephrine; Octreotide; Terlipressin; Treatment Outcome; Vasoconstrictor Agents

2022
AGA Clinical Practice Update on the Evaluation and Management of Acute Kidney Injury in Patients With Cirrhosis: Expert Review.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2022, Volume: 20, Issue:12

    Topics: Acute Kidney Injury; Albumins; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Creatinine; Diuretics; Humans; Liver Cirrhosis; Midodrine; Necrosis; Norepinephrine; Octreotide; Terlipressin

2022

Trials

2 trial(s) available for midodrine and terlipressin

ArticleYear
Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial.
    Hepatology (Baltimore, Md.), 2015, Volume: 62, Issue:2

    Topics: Aged; Albumins; Analysis of Variance; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatorenal Syndrome; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Kidney Function Tests; Liver Function Tests; Lypressin; Male; Middle Aged; Midodrine; Octreotide; Predictive Value of Tests; Survival Analysis; Terlipressin; Treatment Outcome

2015
Effect of different therapeutic modalities on systemic, renal, and hepatic hemodynamics and short-term outcomes in cirrhotic patients with spontaneous bacterial peritonitis.
    European journal of gastroenterology & hepatology, 2016, Volume: 28, Issue:7

    Topics: Adult; Bacterial Infections; Drug Therapy, Combination; Female; Hemodynamics; Hepatorenal Syndrome; Humans; Liver Circulation; Liver Cirrhosis; Lypressin; Male; Middle Aged; Midodrine; Peritonitis; Renal Circulation; Serum Albumin; Terlipressin; Treatment Outcome; Vasoconstrictor Agents

2016

Other Studies

3 other study(ies) available for midodrine and terlipressin

ArticleYear
Vasoconstrictor therapy for patients with cirrhosis with ascites but without hepatorenal syndrome.
    Hepatology (Baltimore, Md.), 2008, Volume: 48, Issue:2

    Topics: Adrenergic alpha-Agonists; Ascites; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Midodrine; Terlipressin; Vasoconstrictor Agents

2008
Midodrine in the prevention of hepatorenal syndrome type 2 recurrence: a case-control study.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2009, Volume: 41, Issue:4

    Topics: Case-Control Studies; Drug Administration Schedule; Female; Hepatorenal Syndrome; Humans; Lypressin; Male; Middle Aged; Midodrine; Prospective Studies; Secondary Prevention; Terlipressin; Treatment Outcome; Vasoconstrictor Agents

2009
Terlipressin is superior to midodrine/octreotide for hepatorenal syndrome type 1.
    European journal of gastroenterology & hepatology, 2017, Volume: 29, Issue:12

    Topics: Drug Therapy, Combination; Hepatorenal Syndrome; Humans; Lypressin; Midodrine; Octreotide; Retrospective Studies; Terlipressin; Treatment Outcome; Vasoconstrictor Agents

2017